SBCWW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 16.5%
- Operating margin
- 41.1%
- Revenue growth YoY
- -9.0%
- Dividend yield
- —
- Beta
- 0.59
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
3 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About SBC Medical Group Holdings Incorporated
Company profileSBC Medical Group Holdings Incorporated is an innovative leader in the healthcare sector, specializing in the development of advanced medical technologies and integrated solutions aimed at improving patient care. The company concentrates on diagnostic tools and disease management systems, utilizing cutting-edge research to enhance treatment efficacy and health outcomes. With its unwavering commitment to quality and continuous innovation, SBC is well-positioned to tackle significant healthcare challenges, providing a pathway for sustainable growth and delivering long-term value for its…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 200 SPECTRUM CENTER DR., IRVINE, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer